Apr122021 Anavex Life Sciences Reports the Results of Review by the Independent Data Safety Monitoring Board for its Phase 2/3 Trials of ANAVEX®2-73 in Patients with Rett Syndrome April 12, 2021
Apr82021 Anavex Life Sciences to Present at the 20th Annual Needham Virtual Healthcare Conference April 8, 2021
Apr72021 Anavex Life Sciences Announces Participation at Upcoming World EPA – Evidence, Pricing and Access – Congress 2021 April 7, 2021
Mar312021 Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease March 31, 2021
Mar42021 Anavex Life Sciences to Present at the H.C. Wainwright Global Life Sciences Conference March 4, 2021
Feb222021 Anavex Life Sciences Announces Participation at Upcoming Worldwide National Institutes of Health (NIH) Panel at Rare Disease Day® February 22, 2021
Feb192021 Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit – West Coast February 19, 2021
Feb182021 Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021 February 18, 2021
Feb112021 Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook February 11, 2021
Feb82021 Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021 February 8, 2021
Jan62021 Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference January 6, 2021
Dec282020 Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates December 28, 2020
